|
|
肌酐与胱抑素C及两者比值在肾脏疾病中的研究进展
|
Abstract:
肌酐/胱抑素C比值(CCR)作为一种新兴的生物标志物，在评估肾功能方面备受关注。本综述旨在系统性地总结CCR与肾功能的关系，探讨其在临床实践中的应用和意义。首先，我们介绍了肌酐和胱抑素C作为肾功能指标的基本特点，并分析了传统肌酐测定方法存在的局限性。随后，我们深入探讨了胱抑素C作为一种新型生物标志物的优势，以及CCR作为评估肾功能的新方法。接着，我们综述了近年来关于肌酐/胱抑素C比值在不同临床情境下的应用，包括慢性肾病、急性肾损伤和肾移植评估。最后，我们讨论了CCR在肾功能评估中的潜在影响，以及未来研究的方向。综合而言，CCR作为一种新兴的生物标志物，在评估肾功能方面具有潜在的临床应用前景，但仍需要进一步的研究和验证来确定其在临床实践中的准确性和可靠性。
The creatinine-cystatin C ratio (CCR) has garnered significant attention as an emerging biomarker in the assessment of renal function. This review aims to systematically summarize the relationship between CCR and renal function, and explore its applications and significance in clinical practice. Firstly, we introduce creatinine and cystatin C as fundamental indicators of renal function and analyze the limitations of traditional creatinine measurement methods. Subsequently, we delve into the advantages of cystatin C as a novel biomarker and discuss CCR as a new approach for evaluating renal function. Furthermore, we review the recent applications of CCR in various clinical contexts, including chronic kidney disease, acute kidney injury, and renal transplant evaluation. Finally, we discuss the potential impact of CCR on renal function assessment and outline future research directions. In conclusion, CCR shows promising clinical prospects as an emerging biomarker for assessing renal function, but further research and validation are required to determine its accuracy and reliability in clinical practice.
| [1] | Ammirati, A.L. (2020) Chronic Kidney Disease. Revista da Associacao Medica Brasileira, 66, S3-S9. https://doi.org/10.1590/1806-9282.66.s1.3 |
| [2] | Eckardt, K.U., Coresh, J., Devuyst, O., et al. (2013) Evolving Importance of Kidney Disease: From Subspecialty to Global Health Burden. The Lancet, 382, 158-169. https://doi.org/10.1016/S0140-6736(13)60439-0 |
| [3] | Kovesdy, C.P., Furth, S.L. and Zoccali, C. (2017) Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Brazilian Journal of Medical and Biological Research, 50, e6075. https://doi.org/10.1177/2054358117698669 |
| [4] | Ng, J.K. and Li, P.K. (2018) Chronic Kidney Disease Epidemic: How Do We Deal with It? Nephrology (Carlton), 23, 116-120. https://doi.org/10.1111/nep.13464 |
| [5] | Ferguson, T.W., Komenda, P. and Tangri, N. (2015) Cystatin C as a Biomarker for Estimating Glomerular Filtration Rate. Current Opinion in Nephrology and Hypertension, 24, 295-300. https://doi.org/10.1097/MNH.0000000000000115 |
| [6] | Abrahamson, M., Olafsson, I., Palsdottir, A., et al. (1990) Structure and Expression of the Human Cystatin C Gene. Biochemical Journal, 268, 287-294. https://doi.org/10.1042/bj2680287 |
| [7] | Tlemsani, C., Durand, J.P., Raynard, B., et al. (2022) Relationship between the Creatinine/Cystatin C Ratio and Muscle Mass Measured by CT-Scan in Cancer Patients. Clinical Nutrition ESPEN, 51, 412-418. https://doi.org/10.1016/j.clnesp.2022.07.010 |
| [8] | Priyadarshini, G. and Rajappa, M. (2022) Predictive Markers in Chronic Kidney Disease. Clinica Chimica Acta, 535, 180-186. https://doi.org/10.1016/j.cca.2022.08.018 |
| [9] | Fujita, K., Ohkubo, H., Nakano, A., et al. (2022) Serum Creatinine/Cystatin C Ratio Is a Surrogate Marker for Sarcopenia in Patients with Idiopathic Pulmonary Fibrosis. BMC Pulmonary Medicine, 22, Article No. 203. https://doi.org/10.1186/s12890-022-02000-3 |
| [10] | Jiang, R., Huang, Y., Zeng, M., et al. (2023) A Marked Elevation in Serum Creatinine/Cystatin C Ratio May Indicate Pseudo-Acute Kidney Injury Due to Urinary Ascites: A Case Report and Literature Review. BMC Nephrology, 24, Article No. 243. https://doi.org/10.1186/s12882-023-03289-w |
| [11] | Khang, A.R., Jin, L.M., Yi, D., et al. (2023) The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients. Diabetes & Metabolism Journal, 47, 415-425. https://doi.org/10.4093/dmj.2022.0177 |
| [12] | Grams, M.E., Coresh, J., Matsushita, K., et al. (2023) Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. JAMA, 330, 1266-1277. https://doi.org/10.1001/jama.2023.17002 |
| [13] | Levey, A.S., Becker, C. and Inker, L.A. (2015) Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults: A Systematic Review. JAMA, 313, 837-846. https://doi.org/10.1001/jama.2015.0602 |
| [14] | Haines, R.W., Fowler, A.J., Liang, K., et al. (2023) Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness. Clinical Journal of the American Society of Nephrology, 18, 997-1005. https://doi.org/10.2215/CJN.0000000000000203 |
| [15] | Wang, J., Zhang, L.X., Tang, C.W., et al. (2018) Disease Burden and Challenges of Chronic Kidney Disease in North and East Asia. Kidney International, 94, 22-25. https://doi.org/10.1016/j.kint.2017.12.022 |
| [16] | Kim, H., Park, T.J., Lee, J., et al. (2021) The Difference between Cystatin C-and Creatinine-Based EGFR Is Associated with Adverse Cardiovascular Outcome in Patients with Chronic Kidney Disease. Atherosclerosis, 335, 53-61. https://doi.org/10.1016/j.atherosclerosis.2021.08.036 |
| [17] | Wang, X.H. and Mitch, W.E. (2014) Mechanisms of Muscle Wasting in Chronic Kidney Disease. Nature Reviews Nephrology, 10, 504-516. https://doi.org/10.1038/nrneph.2014.112 |
| [18] | Pereira, R.A., Cordeiro, C.A., Avesani, C.M., et al. (2015) Sarcopenia in Chronic Kidney Disease on Conservative Therapy: Prevalence and Association with Mortality. Nephrology Dialysis Transplantation, 30, 1718-1725. https://doi.org/10.1093/ndt/gfv133 |
| [19] | Carrero, J.J., Johansen, K.L., Lindholm, B., et al. (2016) Screening for Muscle Wasting and Dysfunction in Patients with Chronic Kidney Disease. Kidney International, 90, 53-66. https://doi.org/10.1016/j.kint.2016.02.025 |
| [20] | Yanishi, M., Kimura, Y., Tsukaguchi, H., et al. (2017) Factors Associated with the Development of Sarcopenia in Kidney Transplant Recipients. Transplantation Proceedings, 49, 288-292. https://doi.org/10.1016/j.transproceed.2016.12.015 |
| [21] | Yanishi, M., Tsukaguchi, H., Kimura, Y., et al. (2017) Evaluation of Physical Activity in Sarcopenic Conditions of Kidney Transplantation Recipients. International Urology and Nephrology, 49, 1779-1784. https://doi.org/10.1007/s11255-017-1661-4 |
| [22] | Choi, M.C., Kim, D.G., Yim, S.H., et al. (2024) Creatinine-Cystatin C Ratio and Death with a Functioning Graft in Kidney Transplant Recipients. Scientific Reports, 14, Article No. 1966. https://doi.org/10.1038/s41598-024-52649-5 |
| [23] | Kellum, J.A., Romagnani, P., Ashuntantang, G., et al. (2021) Acute Kidney Injury. Nature Reviews Disease Primers, 7, Article No. 52. https://doi.org/10.1038/s41572-021-00284-z |
| [24] | Koza, Y. (2016) Acute Kidney Injury: Current Concepts and New Insights. Journal of Injury and Violence Research, 8, 58-62. |
